Warren Wade
32Patents
6h-index
59Co-inventors
68Inventor score
Filing activity: Mar 8, 2004 → Mar 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7056927B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 26 | Expired |
| US7419983B2 | Gonadotropin-releasing hormone receptor antagonists and methods related thereto | Chemistry; Metallurgy | 25 | Active |
| US7176211B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 23 | Expired |
| US9422310B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 15 | Active |
| US8084614B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 8 | Active |
| US7229995B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 7 | Expired |
| US7015226B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 6 | Expired |
| US8481738B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 6 | Active |
| US9040714B2 | IRE-1α inhibitors | Emerging Cross-Sectional Technologies | 5 | Active |
| US8952161B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 3 | Active |
| US9693992B2 | IRE-1α inhibitors | Emerging Cross-Sectional Technologies | 3 | Active |
| US8674095B2 | Compounds for treating neuropsychiatric conditions | Chemistry; Metallurgy | 2 | Active |
| US8372970B2 | 8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | Human Necessities | 2 | Active |
| US10336769B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 2 | Active |
| US8680099B2 | 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | Human Necessities | 2 | Active |
| US9867803B2 | IRE-1α inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US7067509B2 | Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto | Chemistry; Metallurgy | 1 | Expired |
| US10941159B2 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Chemistry; Metallurgy | 1 | Active |
| US8912203B2 | 6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders | Physics | 1 | Active |
| US9493435B2 | IRE-1α inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10100045B2 | 3-aryl-2H-pyrazolo[4,3-b]pyridine compounds and their use as AMPA receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US10357475B2 | IRE-1α inhibitors | Emerging Cross-Sectional Technologies | 1 | Active |
| US10087185B2 | Fused bicylic pyridine compounds and their use as AMPA receptor modulators | Chemistry; Metallurgy | 1 | Active |
| US9946847B2 | Libraries of compounds having desired properties and methods for making and using them | Physics | 0 | Active |
| US7378552B2 | Monoamine re-uptake inhibitors and methods relating thereto | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.